Diabetes Medication Safety Quiz

Which class of medications has been linked to an increased risk of genital infections and UTIs?

Which diabetes medication has been linked to an increased risk of heart failure?

Which diabetes medication has been associated with hepatotoxicity, or liver damage?

Which condition is a potential side effect of insulin, sulfonylureas, meglitinides, and pramlintide?

Which class of medications can lead to hypotension and dehydration?

Which diabetes medication can result in hypokalemia, a condition characterized by low potassium levels in the blood?

Which severe complication is associated with SGLT2 Inhibitors?

Which diabetes medication is associated with lactic acidosis, a potentially life-threatening condition?

Which medications have been linked to an increased risk of osteopenia and osteoporosis?

Which diabetes medication has been associated with an increased risk of pancreatitis?

Which condition is Canagliflozin linked to?

Which diabetes medication should individuals with renal insufficiency consider for dose adjustments?

Which medication has been associated with an increased risk of bladder cancer?

Which class of medication has been linked to an increased risk of thyroid cancer, including medullary thyroid carcinoma?

What is the primary concern associated with the use of GLP-1 agonists?

Which medication class is known to be associated with an increased risk of gastroparesis and gastrointestinal disorders?

Which medication is specifically mentioned for its association with an increased risk of bladder cancer?

What is the primary concern associated with the use of pioglitazone?

Which medication class is used to stimulate the release of insulin in response to elevated blood sugar levels?

Which medication is not mentioned as being associated with any specific cancer risk?

Which class of medication has been linked to an increased risk of thyroid cancer?

What should individuals taking pioglitazone be aware of?

Which medication class has been associated with an increased risk of bladder cancer?

What is the primary concern associated with the use of GLP-1 agonists?

Pioglitazone is associated with an increased risk of bladder cancer.

GLP-1 agonists have been linked to an increased risk of thyroid cancer, including medullary thyroid carcinoma.

Gastroparesis and gastrointestinal disorders are potential safety concerns associated with certain diabetes medications.

The text mentions medications belonging to the class of thiazolidinediones (TZDs) as being linked to cancer risk.

True or false: Canagliflozin has been linked to peripheral neuropathy, peripheral arterial disease (PAD), and foot ulcers.

True or false: Alogliptin, saxagliptin, and TZDs have been associated with heart failure.

True or false: Insulin use has been associated with hepatotoxicity, or liver damage.

True or false: SGLT2 inhibitors have been linked to an increased risk of genital infections and UTIs.

True or false: Metformin is associated with lactic acidosis, a potentially life-threatening condition.

True or false: Sulfonylureas, meglitinides, TZDs, and insulin use have been associated with weight gain and an increased risk of obesity.

True or false: GLP-1 agonists have been associated with an increased risk of gastroparesis and gastrointestinal disorders.

True or false: DPP-4 inhibitors and GLP-1 agonists have been associated with an increased risk of pancreatitis.

True or false: SGLT2 inhibitors can lead to hypotension and dehydration.

True or false: Pramlintide, a drug used to manage diabetes, can lead to gastroparesis.

True or false: Individuals with renal insufficiency may need dose adjustments for metformin, SGLT2 inhibitors, exenatide, and glyburide.

True or false: Individuals with a severe sulfa allergy should avoid sulfonylureas due to the potential for allergic reactions.

What are the potential cancer risks associated with pioglitazone and GLP-1 agonists?

What is the primary concern associated with the use of pioglitazone?

Which medication class is linked to an increased risk of gastroparesis and gastrointestinal disorders?

What are the potential conditions associated with GLP-1 agonists?

What are the potential safety concerns associated with the use of SGLT2 inhibitors?

Which diabetes medications have been linked to heart failure?

What is hepatotoxicity, and which medications are associated with this concern?

What is hypoglycemia, and which medications can lead to this condition?

What is hypokalemia, and which medication can result in this condition?

What is ketoacidosis, and which medication is associated with this severe complication?

What is lactic acidosis, and which medication is associated with this potentially life-threatening condition?

Which diabetes medications have been linked to an increased risk of osteopenia and osteoporosis?

What is pancreatitis, and which medications have been associated with an increased risk of this condition?

Which diabetes medication is specifically linked to peripheral neuropathy, peripheral arterial disease (PAD), and foot ulcers?

What safety concern is associated with the use of sulfonylureas, meglitinides, TZDs, and insulin?

In individuals with renal insufficiency, which specific diabetes medications may need dose adjustments?